BPA Call VA25517A0007-VA25517J2639
- This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the provision of MRSA and C. diff test kits and reagents. The award, valued at $883,413.29, was made by the Department of Veterans Affairs (VA) Veterans Health Administration under a Blanket Purchase Agreement (BPA) call against a General Services Administration (GSA) Schedule contract for In Vitro Diagnostics, Reagents, and Tests. The contract has a firm-fixed price pricing type and a...
- This is a firm fixed-price BPA call contract awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, with a ceiling value of $7,559,248.97, is for the procurement of MRSA and C. diff test kits to support clinical testing programs serving veterans. The contract is not set aside and is awarded under the VA's Indefinite Delivery Vehicle (IDV) contract for In...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $104,930.64 contract is for the delivery of MRSA, C-DIFF, and XPRSFLU test kits to support the VA's clinical diagnostic programs. The contract does not have a set-aside designation. Cepheid is the prime contractor and sole provider for this award. As the original equipment manufacturer of the...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for MRSA test kits. The contract has a potential value of $180,055.09 and is funded through the Veterans Integrated Service Network 19. Cepheid, which is a subsidiary of the Danaher Corporation, has provided a range of diagnostic testing products and services to federal agencies including the...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostics solutions, to provide cost per test services for MRSA nasal, MRSA blood, influenza, C. diff, GC/NG, and other infectious disease tests. The $398,339.20 contract has an August 2019 completion date and was not set aside. Cepheid, a subsidiary of Danaher Corporation, provides reagents, test kits, instruments, and...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, valued at $82,752.48, is a delivery order issued under Cepheid's General Services Administration (GSA) Federal Supply Schedule (FSS) contract for In-Vitro Diagnostics, Reagents, and Test Kits. The contract is for the provision of MRSA, C. diff, and flu test kits to the Department of Veterans Affairs (VA) Veterans...
- This is a Firm Fixed Price contract awarded by the Veterans Integrated Service Network 15 (VISN 15) of the Department of Veterans Affairs (VA) to Cepheid Inc., a subsidiary of Danaher Corporation, to provide MRSA and C. diff test kits. The contract has a ceiling value of $1,094,214.11 and a period of performance through June 30, 2017. It was awarded on July 1, 2016 and is not a set-aside contract. Cepheid is a leading manufacturer of molecular diagnostic solutions, including infectious disease...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 to the prime contractor Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $956,060.20 Firm Fixed Price Delivery Order is for the provision of Cepheid's C-DIFF, MRSA, and H1N1 test kits under the VA's Indefinite Delivery Vehicle for In Vitro Diagnostics, Reagents, and Test products. The contract has no set-aside designation. Cepheid, as the original...
- This is a Firm Fixed Price Delivery Order contract awarded by the Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $94,997.30, is to provide MRSA test kits. The contract is under the VA's Indefinite Delivery Vehicle (IDV) for Invitro Diagnostics, Reagents, and Test equipment (FSS-65-VII), which enables the VA to continuously procure Cepheid's molecular diagnostic solutions to support clinical testing programs for...
- This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases. The contract, valued at $679,449.60, is for the delivery of MRSA/C. diff diagnostic products and services, including reagents, test kits, instruments, and testing platforms. The contract was awarded on a firm fixed-price basis under the GSA Scientific Equipment and...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- V797P5967X-VA25517A0007Blanket Purchase Agreement
- VA25517A0007-VA25517J2639BPA Call
This is a firm-fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $5,994,214.67, is for the provision of MRSA and C. diff test kits and is funded through the VA's Invitro Diagnostics, Reagents, Test (FSS-65-VII) federal supply schedule. As the original equipment manufacturer, Cepheid will deliver reagents, test kits, instruments, and testing platforms to support the VA's clinical diagnostic programs. Cepheid is a subsidiary of the Danaher Corporation and has also received awards from other federal agencies, including the Defense Logistics Agency and the Department of Health and Human Services, to supply infectious disease testing products and services. This contract does not utilize a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Funding Only Action | $4.5k | 4/11/19 | |
| P00003 | Funding Only Action | ($189k) | 1/3/19 | |
| Not listed | Not listed | $1.3m | 3/8/17 |